Browse the latest research summaries in the field of immunology for spinal cord injury patients and caregivers.
Showing 171-180 of 730 results
Advanced Science, 2024 • November 27, 2023
This study investigates the role of the cGas-Sting signaling pathway in microglia after spinal cord injury (SCI). The findings indicate that Sting is activated in microglia after SCI, triggering an in...
KEY FINDING: Sting expression is increased in activated microglia after SCI, and knockout of Sting in microglia improves neurological function recovery after SCI.
Cureus, 2023 • October 16, 2023
This is a rare case of spontaneous intramedullary spinal cord hemorrhage in a patient with BS. The existing literature documenting cases of spontaneous hemorrhages in patients with BS reflects the imm...
KEY FINDING: The case presents the first reported instance of an abrupt onset of neurological injury secondary to intramedullary spinal cord bleed in Behcet’s syndrome.
Frontiers in Immunology, 2023 • November 8, 2023
This review describes the current understanding of the JAK-STAT signaling in neuroendocrine homeostasis and diseases, together with the rationale for targeting at this pathway for the treatment of SCI...
KEY FINDING: The JAK/STAT pathway is involved in the proliferation and differentiation of neural stem cells, promoting the regeneration of astrocytes and inducing the differentiation of neurons and oligodendrocytes.
Rheumatology Advances in Practice, 2023 • November 20, 2023
This review discusses the efficacy of stem cell therapy (SCT) using mesenchymal stem cells (MSCs) and hematopoietic stem cells (HSCs) for systemic sclerosis (SSc). Both MSCT and HSCT could improve dis...
KEY FINDING: Mesenchymal stem cells (MSCs) and hematopoietic stem cells (HSCs) improve disease activity and severity in SSc patients.
Materials Today Bio, 2023 • November 29, 2023
This review summarizes the current understanding of astrocyte-mediated inflammation in TSCI and the potential of nanomaterials to manage this inflammation. It classifies nanomaterials into organic, bi...
KEY FINDING: Organic nanomaterials, like PLGA nanoparticles, can effectively reduce the production of inflammatory factors by astrocytes and restrict glial scarring, improving behavioral performance in rats.
BMC Surgery, 2023 • December 5, 2023
This study compares titanium mesh and bone grafting for spinal tuberculosis. The results show both methods are effective and safe. There were no significant differences in surgical duration, blood los...
KEY FINDING: There's no significant difference in surgery duration between titanium mesh and bone grafting.
NEURAL REGENERATION RESEARCH, 2024 • December 11, 2023
Spinal cord injury can be traumatic or non-traumatic in origin, with the latter rising in incidence and prevalence with the aging demographics of our society. Understanding key processes and existing ...
KEY FINDING: Following SCI, increased extracellular ATP serves as a damage-associated molecular pattern signal molecule as it is released from ruptured and apoptotic cells.
Journal of Neuroinflammation, 2023 • December 4, 2023
This study evaluated the effects of hyperbaric oxygen (HBO) and normobaric oxygen therapy on neuroinflammation and respiratory recovery in a rat model of spinal cord injury (SCI). The key finding was ...
KEY FINDING: Both hyperbaric and normobaric oxygen therapy significantly reduced the inflammatory response in the injured spinal cord, as evidenced by transcriptomic analysis and immunohistochemical markers for astrocytes and microglia.
Therapeutic Advances in Neurological Disorders, 2023 • September 15, 2023
This retrospective cohort study of 84 patients with neurosarcoidosis (NS) aimed to define disease courses based on initial presentation and treatment. The study identified three main disease courses: ...
KEY FINDING: Neurosarcoidosis is primarily a relapsing disease, with no patients exhibiting a progressive course in this cohort.
Theranostics, 2024 • January 1, 2024
This study investigates the underlying mechanisms of MSC-mediated SCI repair using HA-MSC scaffolds and reveals the dominant role of IL-10 in MSC treatment for spinal cord repair. The research demonst...
KEY FINDING: HA scaffolds improve MSC survival and inhibit neuroinflammation after SCI, as evidenced by decreased pro-inflammatory cytokines and increased anti-inflammatory cytokines.